List view / Grid view
Strike NGS workflow gold with our broad portfolio of automation solutions, delivering reliable, high-throughput results. But don't take our word for it! Hear from our customer.
Check out our library of NGS-related webinars from global researchers and industry professionals to explore possibilities with our Biomek automated workstations and Echo acoustic liquid handlers.
Generate accurate data by automating your NGS workflows with Beckman Coulter Life Sciences’ flexible automated liquid handling solutions that deliver reliable results.
Explore how to apply our acoustic and tip-based liquid handling solutions for your NGS workflows in metagenomics, sample QC, RNASeq, microbiome, SARS-CoV 2 to name a few.
Automation solutions from Beckman Coulter Life Sciences alleviate your library prep pain points, whether you need automation for a few samples or a high-throughput solution.
Work with one trusted partner for instruments, software, consumables and service to help keep your laboratory running smoothly. Smooth processes save time, money and maximise your lab’s ROI.
Join leading experts as they discuss the wide range of uses for CRISPR, including for therapeutics and biomanufacturing.
Researchers analysed the expression of long non-coding RNAs in samples from patients and tumour cell lines, identifying a group of genes with augmented expression in pancreatic cancer.
Scientists have published a report on the whole genome sequences of 150 thousand participants in the UK biobank.
A new single-cell nanoparticle targeting-sequencing approach can measure the cellular uptake of lipid nanoparticles carrying mRNA therapies.
Researchers in the US have found that antibodies to the SARS-CoV-2 Spike protein can be produced in hen eggs.
Droplet Digital PCR (ddPCR) offers greater accuracy and precision in quantifying viral titer in gene therapies.
Researchers have developed a two-step approach using whole exome sequencing to focus on genes and pathways that predict whether cancer patients will respond to immunotherapy.
The new immune gene networks have implications for developing immunotherapies and understanding autoimmune diseases.
Researchers have created artificial Hox genes using new synthetic DNA technology and genomic engineering in stem cells.
